Privia Health Group, Inc. (PRVA) has a consensus analyst rating of Buy, based on 22 analysts covering the stock. Of those, 20 recommend buying, 2 recommend holding, and 0 recommend selling.
The analyst consensus price target for PRVA is $31.00, representing a +34.1% upside from the current price of $23.12. Price targets range from a low of $22.00 to a high of $36.00.
